Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Cambau
E
E
Laboratoire de Recharche Moléculaire sur les Antibiotiques, Faculté de Médecine Pitié-Salpêtrière, Université Paris VI, France.
Perani
E
E
Guillemin
I
I
Jamet
P
P
Ji
B
B
D000328:Adult; D000890:Anti-Infective Agents / Q000494:pharmacology*; D003622:Dapsone / Q000494:pharmacology*; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000494:pharmacology*; D015440:Leprosy, Lepromatous / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D009166:Mycobacterium leprae / Q000187:drug effects* / Q000235:genetics; D015242:Ofloxacin / Q000494:pharmacology*; D012293:Rifampin / Q000494:pharmacology*
D000890:Anti-Infective Agents; D007917:Leprostatic Agents; D003622:Dapsone; D015242:Ofloxacin; D012293:Rifampin